Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2011
03/17/2011US20110065139 diagnostic device for identifying rupture of membrane during pregnancy
03/17/2011US20110065138 Quantitative Method For Detecting Yessotoxins In Fishery Products On Based On The Activation That The Toxin Produces In Cellular Phosphodiesterases And Therapeutic Use Of This Activation
03/17/2011US20110065137 Methods and Devices for Detecting Obstructive Uropathy and Associated Disorders
03/17/2011US20110065136 Methods and Devices for Detecting Glomerulonephritis and Associated Disorders
03/17/2011US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases
03/17/2011US20110065128 Methods for Assessing CDK5 Activation and Function
03/17/2011US20110065125 Controlled platelet activation to monitor therapy of adp antagonists
03/17/2011US20110065123 Methods for diagnosis of Clostridium difficile and methods and vectors for recombinant toxin expression
03/17/2011US20110065122 Method for accessing microbial diversity
03/17/2011US20110065121 Method for the detection of apoptosis
03/17/2011US20110065120 Method and a Reagent kit to Improve the Accuracy of Sample Classification
03/17/2011US20110065119 Reverse progeny mapping
03/17/2011US20110065118 Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
03/17/2011US20110065117 Mesothelioma Specific Transferred Promoter And Use Thereof
03/17/2011US20110065116 Method for Detecting ATP
03/17/2011US20110065115 Methods for identifying an increased likelihood of recurrence of breast cancer
03/17/2011US20110065114 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals
03/17/2011US20110065113 Recurrent gene fusions in prostate cancer
03/17/2011US20110065112 Method for identifying lineage-related antibodies
03/17/2011US20110065111 Compositions For Use In Genotyping Of Klebsiella Pneumoniae
03/17/2011US20110065110 Method For The Extraction And Purification Of Nucleic Acids On A Membrane
03/17/2011US20110065109 Rna interference mediating small rna molecules
03/17/2011US20110065108 Urine Transport Medium
03/17/2011US20110065107 Detection of gleevec resistance
03/17/2011US20110065106 Recombinase polymerase amplification
03/17/2011US20110065105 Novel transcription factor-based biosensor
03/17/2011US20110065104 Real-time assays of neuro-humoral factors to assess cardiovascular stress
03/17/2011US20110065103 Use of rna for reprogramming somatic cells
03/17/2011US20110065102 Osteoarthritis-sensitive gene
03/17/2011US20110065101 Multiple-sample microfluidic chip for DNA analysis
03/17/2011US20110065100 Transcription biomarkers of biological responses and methods
03/17/2011US20110065099 Method of pretreating specimen and immunoassay using the same
03/17/2011US20110065098 Methods and reagent kits for improving accuracy of sample classification
03/17/2011US20110065097 Apparatus and Method of Contaminant Detection for Food Industry
03/17/2011US20110065096 Viral diagnostic method and well for use in same
03/17/2011US20110065095 Anti-(influenza a virus subtype h5 hemagglutinin) monoclonal antibody
03/17/2011US20110065094 Method and kit for detection/identification of virus-infected cell
03/17/2011US20110065093 Novel tool for the analysis of neural circuits
03/17/2011US20110065092 Use of nonviable particles comprising an internal control (ic) nucleic acid
03/17/2011US20110065091 Coronavirus, Nucleic Acid, Protein, and Methods for the Generation of Vaccine, Medicaments and Diagnostics
03/17/2011US20110065090 Asymmetrically branched polymer conjugates and microarray assays
03/17/2011US20110065089 Novel strain of sars-associated coronavirus and applications thereof
03/17/2011US20110065088 Method and devices for rapid diagnosis of foot-and-mouth disease
03/17/2011US20110065087 Novel hiv targets
03/17/2011US20110065086 Methods of producing homogeneous plastic-adherent aptamer-magnetic bead-fluorophore and other sandwich assays
03/17/2011US20110065085 Novel heparin entities and methods of use
03/17/2011US20110064766 Attenuated Vaccine Against Fish Pathogen Francisella Sp.
03/17/2011US20110064757 Nucleic acid molecules and polypeptides for immune modulation
03/17/2011US20110064747 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10)
03/17/2011US20110064739 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung
03/17/2011US20110064730 Method of modulating angiogenesis
03/17/2011US20110064722 Modulators of alpha-synuclein toxicity
03/17/2011US20110064721 Cathepsin-d neuroprotection
03/17/2011US20110064701 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
03/17/2011US20110064674 Luminescent multimodal nanoparticle probe system and method of manufacture thereof
03/17/2011US20110064664 Methods and compositions involving chitosan nanoparticles
03/17/2011US20110062033 Implantable Electrochemical Biosensor System and Method
03/17/2011DE102010029855A1 Sondenmoleküle für die Fluoreszenz bei der In-Situ-Hybridisierung von Oligonukleotiden (Fish) Probe molecules for fluorescence in in situ hybridization of oligonucleotides (FISH)
03/17/2011CA2774173A1 Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
03/17/2011CA2773983A1 Mutant sodium channel nav1.7 and methods related thereto
03/17/2011CA2773887A1 Compositions and methods for whole transcriptome analysis
03/17/2011CA2773746A1 Peptide nucleic acid probes, kit and method for detecting helicobacter pylori and/or clarithromycin resistance profile and applications
03/17/2011CA2773624A1 Composition and method for imaging stem cells
03/17/2011CA2773340A1 Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
03/17/2011CA2773049A1 Compositions and methods for diagnosing autism spectrum disorders
03/17/2011CA2771771A1 Porcine torque teno virus vaccines and diagnosis
03/16/2011EP2295988A2 Multiplexed molecular analysis apparatus and its fabrication method
03/16/2011EP2295980A1 Molecules and methods using same for measuring non-transferrin bound iron
03/16/2011EP2295978A2 Early pregnancy diagnosis using PAGs(Pregnancy-associated Glycoproteins)
03/16/2011EP2295971A2 Conjugate probes and optical detection of analytes
03/16/2011EP2295606A1 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
03/16/2011EP2295605A1 Method of classifying gene expression strength in lung cancer tissues
03/16/2011EP2295604A2 Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features
03/16/2011EP2295603A1 Method and devices for multiplexing amplification reactions
03/16/2011EP2295602A1 Method of diagnosing esophageal cancer
03/16/2011EP2295601A1 Method of diagnosing bladder cancer
03/16/2011EP2295600A1 Method and test strip for detecting sensitivity to isoniazid in mycobacterium tuberculosis
03/16/2011EP2295599A1 Method for detection of idiopathic interstitial pneumonia
03/16/2011EP2295598A1 Method and kit for detection of cancer, and therapeutic agent for cancer
03/16/2011EP2295597A1 Method of estimating surviving bacteria count and method of setting guaranteed bacteria count
03/16/2011EP2295587A1 Herbicide tolerant cotton plants and methods for identifying same
03/16/2011EP2295586A2 Plant centromere compositions
03/16/2011EP2295580A1 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
03/16/2011EP2295578A2 Cyp1b1 nucleic acids and methods of use
03/16/2011EP2295577A2 Human cytokine as ligand of the z-alpha receptor and uses thereof
03/16/2011EP2295571A1 Method of diagnosing small cell lung cancer
03/16/2011EP2295570A1 Method of diagnosing small cell lung cancer
03/16/2011EP2295567A2 Compositions and methods for using a solid support to purify DNA
03/16/2011EP2295564A1 Composition and method for determination of esophageal cancer
03/16/2011EP2295561A2 Gene group applicable to cancer prognostication
03/16/2011EP2295552A2 Mutations in OAS1 genes
03/16/2011EP2295550A2 Crystal structures of GSK-3beta protein and protein complexes and their use.
03/16/2011EP2295537A1 Human hepatic stem cell, method for preparation of the same, method for induction of differentiation of the same, and method for utilization of the same
03/16/2011EP2295503A1 Dibenzorhodamine dyes useful as fluorescent labelling agents
03/16/2011EP2295454A1 SLO2, a novel potassium channel protein from human brain
03/16/2011EP2295447A1 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
03/16/2011EP2295144A2 System and method for incubating the contents of a reaction receptacle
03/16/2011EP2295074A1 Anti-neovasculature preparations for treating cancer
03/16/2011EP2295070A1 Use of VEGF and homologues to treat neuron disorders
03/16/2011EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha